Imperatorin efficiently blocks TNF-α-mediated activation of ROS/PI3K/Akt/NF-κB pathway

  • Authors:
    • Ke Si Wang
    • Ying Lv
    • Zhe Wang
    • Juan Ma
    • Chunliu Mi
    • Xuezheng Li
    • Guang Hua Xu
    • Lian Xun Piao
    • Sheng Zhe Zheng
    • Xuejun Jin
  • View Affiliations

  • Published online on: April 19, 2017     https://doi.org/10.3892/or.2017.5581
  • Pages: 3397-3404
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Inflammation contributes to development and progression in a variety of cancers, including cervical cancer, which is the second leading cause of cancer deaths in women worldwide. In this study, we examined the anti-inflammatory effects of imperatorin, a psoralen-type furanocoumarin from the fruits of Angelica dahurica, in tumor necrosis factor-α (TNF-α)-stimulated HeLa cells by investigating its impact on the production and expression of cytokines and the major signal-transduction pathways. We found this compound significantly inhibited the TNF-α-induced expression of NF-κB target genes, such as COX-2, cyclin  D1, MMP-9, VEGF, IL-6 and Bcl-xL in a concentration-dependent manner. Further analysis revealed that imperatorin was a potent inhibitor of NF-κB activation by the suppression of TNF-α-induced IKKα/β phosphorylation, IκB phosphorylation and degradation, and NF-κB p65 nuclear translocation. We also demonstrated that imperatorin downregulated TNF-α-induced activation of PI3K/Akt. Furthermore, our findings show that imperatorin inhibits TNF-α-induced ROS generation. Taken together, imperatorin can blunt inflammation by inhibiting the ROS-mediated activation of the PI3K/Akt/NF-κB pathway.
View Figures
View References

Related Articles

Journal Cover

June-2017
Volume 37 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang KS, Lv Y, Wang Z, Ma J, Mi C, Li X, Xu GH, Piao LX, Zheng SZ, Jin X, Jin X, et al: Imperatorin efficiently blocks TNF-α-mediated activation of ROS/PI3K/Akt/NF-κB pathway. Oncol Rep 37: 3397-3404, 2017.
APA
Wang, K.S., Lv, Y., Wang, Z., Ma, J., Mi, C., Li, X. ... Jin, X. (2017). Imperatorin efficiently blocks TNF-α-mediated activation of ROS/PI3K/Akt/NF-κB pathway. Oncology Reports, 37, 3397-3404. https://doi.org/10.3892/or.2017.5581
MLA
Wang, K. S., Lv, Y., Wang, Z., Ma, J., Mi, C., Li, X., Xu, G. H., Piao, L. X., Zheng, S. Z., Jin, X."Imperatorin efficiently blocks TNF-α-mediated activation of ROS/PI3K/Akt/NF-κB pathway". Oncology Reports 37.6 (2017): 3397-3404.
Chicago
Wang, K. S., Lv, Y., Wang, Z., Ma, J., Mi, C., Li, X., Xu, G. H., Piao, L. X., Zheng, S. Z., Jin, X."Imperatorin efficiently blocks TNF-α-mediated activation of ROS/PI3K/Akt/NF-κB pathway". Oncology Reports 37, no. 6 (2017): 3397-3404. https://doi.org/10.3892/or.2017.5581